A Study to Investigate JNJ-40411813 in Combination With Levetiracetam or Brivaracetam in Epilepsy

Clinical trial NCT04836559 · COMPLETED

Trial details

NCT number: NCT04836559
Sponsor: Janssen Research & Development, LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Focal Onset Seizures

Start date: 2021-05-18
Primary completion: 2024-02-08
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.